Immunodeficiencies with Autoimmune Consequences

Advances in Immunology

Volumn 89, Issue , 2006, Pages 321-370

  Notarangelo, Luigi D ^a   Gambineri, Eleonora ^b   Badolato, Raffaele ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOIMMUNE REGULATOR PROTEIN; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INSULIN; RAPAMYCIN; RITUXIMAB; STEROID; TACROLIMUS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3;

ADDISON DISEASE; ARTHRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; BLOOD TRANSFUSION; CD4+ CD25+ T LYMPHOCYTE; CHRONIC GRANULOMATOUS DISEASE; COMBINED IMMUNODEFICIENCY; DIGEORGE SYNDROME; ECZEMA; ENTERITIS; ENTEROPATHY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEPATITIS; HOMEOSTASIS; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPOPARATHYROIDISM; IMMUNE DEFICIENCY; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOPATHOGENESIS; INFECTION COMPLICATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; IPEX SYNDROME; KIDNEY DISEASE; LYMPHOPROLIFERATIVE DISEASE; MOLECULAR DYNAMICS; MOLECULAR GENETICS; MOLECULAR RECOGNITION; MYELOABLATIVE CONDITIONING; NEUTROPENIA; NONHUMAN; OMENN SYNDROME; PARENTERAL NUTRITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SYMPTOMATOLOGY; THROMBOCYTOPENIA; VASCULITIS; WISKOTT ALDRICH SYNDROME; X LINKED AGAMMAGLOBULINEMIA;

ANIMALS; AUTOANTIBODIES; GENETIC DISEASES, X-LINKED; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; POLYENDOCRINOPATHIES, AUTOIMMUNE;

EID: 33748030780     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2776(05)89008-X     Document Type: Review

References (166)

1. Aaltonen J., Bjorses P., Sandkuijl L., Perheentupa J., and Peltonen L. An autosomal locus causing autoimmune disease: Autoimmune polyglandular disease type I assigned to chromosome 21. Nat. Genet. 8 (1994) 83-87
2. Ahonen P., Myllarniemi S., Sipila I., and Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N. Engl. J. Med. 322 (1990) 1829-1836
3. Aleman K., Noordzij J.G., de Groot R., et al. Reviewing Omenn syndrome. Eur. J. Pediatr. 160 (2001) 718-725
4. Anderson M.S., Venanzi E.S., Klein L., Chen Z., Berzins S.P., Turley S.J., von Boehmer H., Bronson R., Dierich A., Benoist C., and Mathis D. Projection of an immunological self shadow within the thymus by the aire protein. Science 298 (2002) 1395-1401
5. Arkwright P.D., Abinun M., and Cant A.J. Autoimmunity in human primary immunodeficiency diseases. Blood 99 (2002) 2694-2702
6. Arvanitakis C., and Knouss R.F. Selective hypopituitarism. Impaired cell-mediated immunity and chronic mucocutaneous candidiasis. JAMA: The Journal of the American Medical Association 225 (1973) 1492-1495
7. Barton L.L., Moussa S.L., Villar R.G., and Hulett R.L. Gastrointestinal complications of chronic granulomatous disease: Case report and literature review. Clin. Pediatr. 37 (1998) 231-236
8. + regulatory T cells. Blood 105 (2005) 4743-4748
9. Baud O., Goulet O., Canioni D., Le Deist F., Radford I., Rieu D., Dupuis-Girod S., Cerf-Bensussan N., Cavazzana-Calvo M., Brousse N., Fischer A., and Casanova J.L. Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N. Engl. J. Med. 344 (2001) 1758-1762
10. Bennett C.L., Brunkow M.E., Ramsdell F., O'Briant K.C., Zhu Q., Fuleihan R.L., Shigeoka A.O., Ochs H.D., and Chance P.F. A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA->AAUGAA) leads to the IPEX syndrome. Immunogenetics 53 (2001) 435-439
11. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., Kelly T.E., Saulsbury F.T., Chance P.F., and Ochs H.D. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27 (2001) 20-21
12. Bennett C.L., Yoshioka R., Kiyosawa H., Barker D.F., Fain P.R., Shigeoka A.O., and Chance P.F. X-Linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhoea maps to Xp11.23-Xq13.3. Am. J. Hum. Genet. 66 (2000) 461-468
13. Bettelli E., Dastrange M., and Oukka M. Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc. Natl. Acad. Sci. USA 102 (2005) 5138-5143
14. Betterle C., Dal Pra C., Mantero F., and Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: Autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr. Rev. 23 (2002) 327-364
15. Bjorses P., Halonen M., Palvimo J.J., Kolmer M., Aaltonen J., Ellonen P., Perheentupa J., Ulmanen I., and Peltonen L. Mutations in the AIRE gene: Effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. Am. J. Hum. Genet. 66 (2000) 378-392
16. Bjorses P., Halonen M., Palvimo J.J., Kolmer M., Aaltonen J., Ellonen P., Perheentupa J., Ulmanen I., and Peltonen L. Mutations in the AIRE gene: Effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. Am. J. Hum. Genet. 66 (2000) 378-392
17. Blair P.J., Bultman S.J., Haas J.C., Rouse B.T., Wilkinson J.E., and Godfrey V.L. CD4+CD8- T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J. Immunol. 153 (1994) 3764-3774
18. Boehm T., Scheu S., Pfeffer K., and Bleul C.C. Thymic medullary epithelial cell differentiation, thymocyte emigration, and the control of autoimmunity require lympho-epithelial cross talk via LTbetaR. J. Exp. Med. 198 (2003) 757-769
19. Bottomley M.J., Stier G., Pennacchini D., Legube G., Simon B., Akhtar A., Sattler M., and Musco G. NMR structure of the first PHD finger of autoimmune regulator protein (AIRE1). Insights into autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) disease. J. Biol. Chem. 280 (2005) 11505-11512
20. Brugnoni D., Airò P., Facchetti F., Blanzuoli L., Ugazio A.G., Cattaneo R., and Notarangelo L.D. In vitro cell death of activated lymphocytes in Omenn's syndrome. Eur. J. Immunol. 27 (1997) 2765-2773
21. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., Wilkinson J.E., Galas D., Ziegler S.F., and Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27 (2001) 68-73
22. Buzi F., Badolato R., Mazza C., Giliani S., Notarangelo L.D., Radetti G., Plebani A., and Notarangelo L.D. Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Syndrome: Time to review diagnostic criteria?. J. Clin. Endocrinol. Metab. 88 (2003) 3146-3148
23. Callebaut I., and Mornon J.P. The VDJ recombination activating protein rag2 consists of a six-bladed propeller and PHD finger-like domain, as revealed by sequence analysis. Cell. Mol. Life 54 (1998) 880-891
24. Candotti F., Notarangelo L., Visconti R., and O'Shea J. Molecular aspects of primary immunodeficiencies: Lessons from cytokine and other signaling pathways. J. Clin. Invest. 109 (2002) 1261-1269
25. Cavadini P., Vermi W., Facchetti F., Fontana S., Nagafuchi S., Mazzolari E., Sediva A., Marrella V., Villa A., Fischer A., Notarangelo L.D., and Badolato R. AIRE deficiency in thymus of 2 patients with Omenn syndrome. J. Clin. Invest. 115 (2005) 728-732
26. Chatila T.A., Blaeser F., Ho N., Lederman H.M., Voulgaropoulos C., Helms C., and Bowcock A.M. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 106 (2000) R75-R81
27. Chilosi M., Facchetti F., Notarangelo L.D., Romagnani S., Del Prete G., Almerigogna F., De Carli F., and Pizzolo G. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: Evidence for a T helper-2 mediated condition. Eur. J. Immunol. 26 (1996) 329-334
28. Chin R.K., Lo J.C., Kim O., Blink S.E., Christiansen P.A., Peterson P., Wang Y., Ware C., and Fu Y.X. Lymphotoxin pathway directs thymic Aire expression. Nat. Immunol. 4 (2003) 1121-1127
29. Clark K.L., Halay E.D., Lai E., and Burley S.K. Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 364 (1993) 412-420
30. Clark L.B., Appleby M.W., Brunkow M.E., Wilkinson J.E., Ziegler S.F., and Ramsdell F. Cellular and molecular characterization of the scurfy mouse mutant. J. Immunol. 162 (1999) 2546-2554
31. Clark R., and Griffiths G.M. Lytic granules, secretory lysosomes, and disease. Curr. Opin. Immunol. (2003) 516-521
32. Clemente M.G., Meloni A., Obermayer-Straub P., Frau F., Manns M.P., and De Virgiliis S. Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1. Gastroenterology 114 (1998) 324-328
33. Clemente M.G., Obermayer-Straub P., Meloni A., Strassburg C.P., Arangino V., Tukey R.H., De Virgiliis S., and Manns M.P. Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1. J. Clin. Endocrinol. Metab. 82 (1997) 1353-1361
34. Cocco C., Meloni A., Boi F., Pinna G., Possenti R., Mariotti S., and Ferri G.L. Median eminence dopaminergic nerve terminals: A novel target in autoimmune polyendocrine syndrome?. J. Clin. Endocrinol. Metab. 90 (2005) 4108-4111
35. Corneo B., Moshous D., Gungor T., Wulfraat N., Philippet F.L., Le Deist A., Fischer A., and de Villartay J.P. Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome. Blood 97 (2001) 2772-2776
36. + regulatory thymocytes. Blood 102 (2003) 4107-4114
37. Dalal I., Tabori U., Bielorai B., Golan H., Rosenthal E., Amariglio N., Rechavi G., and Toren A. Evolution of T-B-SCID into Omenn syndrome phenotype following parainfluenza 3 virus infection. Clin. Immunol. 115 (2005) 70-73
38. + regulatory T cell function. Eur. J. Immunol. 34 (2004) 2480-2488
39. Denianke K.S., Frieden I.J., Cowan M.J., Williams M.L., and McCalmont T.H. Cutaneous manifestations of maternal engraftment in patients with severe combined immunodeficiency: A clinicopathological study. Bone Marrow Transplant. 28 (2001) 227-233
40. Derbinski J., Gabler J., Brors B., Tierling S., Jonnakuty S., Hergenhahn M., Peltonen L., Walter J., and Kyewski B. Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J. Exp. Med. 202 (2005) 33-45
41. de Saint Basile G., Le Deist F., de Villartay J.P., Cerf-Bensussan N., Journet O., Brousse N., Griscelli C., and Fischer A. Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). J. Clin. Invest. 87 (1991) 1352-1359
42. Di Rocco M., and Marta R. X linked immune dysregulation, neonatal insulin dependent diabetes, and intractable diarrhoea. Arch. Dis. Child Fetal Neonatal Ed. 75 (1996) F144
43. Ege M., Ma Y., Manfras B., Kalwak K., Lu H., Lieber M.R., Schwarz K., and Pannicke U. Omenn syndrome due to ARTEMIS mutations. Blood 105 (2005) 4179-4186
44. Ekwall O., Hedstrand H., Grimelius L., Haavik J., Perheentupa J., Gustafsson J., Husebye E., Kampe O., and Rorsman F. Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet 352 (1998) 279-283
45. Etzioni A. Immune deficiency and autoimmunity. Autoimmunity Reviews 2 (2003) 364-369
46. Facchetti F., Blanzuoli L., Ungari M., Alebardi O., and Vermi W. Lymph node pathology in primary combined immunodeficiency diseases. Springer Semin. Immunopathol. 19 (1998) 459-478
47. Ferguson P.J., Blanton S.H., Saulsbury F.T., McDuffie M.J., Lemahieu V., Gastier J.M., Francke U., Borowitz S.M., Sutphen J.L., and Kelly T.E. Manifestations and linkage analysis in X-linked autoimmunity-immunodeficiency syndrome. Am. J. Med. Genet. 90 (2000) 390-397
48. + regulatory T cells. Nat. Immunol. 4 (2003) 330-336
49. Fontenot J.D., and Rudensky A.Y. A well adapted regulatory contrivance: Regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 6 (2005) 331-337
50. Franzese A., Valerio G., Di Maio S., Iannucci M.P., Bloise A., and Tenore A. Growth hormone insufficiency in a girl with the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J. Endocrinol. Invest. 22 (1999) 66-69
51. Frucht D.M., Gadina M., Jagadees G.J., Aksentijevic I., Takata K., Blessing J., Nelson J., Muul L.M., Perham T.G.M., Morgan G., Gerritsne E.J.A., Schumacher R.F., Mella P., Veys P., Fleisher T.A., Kaminsky E.R., Notarangelo L.D., O'Shea J.J., and Candotti F. Unexpected and variable phenotypes in a family with JAK3 deficiency. Genes Immun. 2 (2001) 422-432
52. Gambineri E., Torgerson T.R., and Ochs H.D. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T cell homeostasis. Curr. Opin. Rheumatol. 15 (2003) 430-435
53. Gennery A.R., Hodges E., Williams A.P., Harris S., Villa A., Angus B., Cant A.J., and Smith J.L. Omenn's syndrome occurring in patients without mutations in recombinase activating genes. Clin. Immunol. 116 (2005) 246-256
54. Godfrey V.L., Wilkinson J.E., and Russell L.B. X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am. J. Pathol. 138 (1991) 1379-1387
55. Gomez C.A., Ptaszek L.M., Villa A., Bozzi F., Sobacchi C., Brooks E.G., Notarangelo L.D., Spanopoulou E., Pan Z.Q., Vezzoni P., Cortes P., and Santagata S. Mutations in conserved regions of the predicted RAG2 kelch repeats block initiation of V(D)J recombination and result in primary immunodeficiencies. Mol. Cell. Biol. 20 (2000) 5653-5664
56. Green E.A., Choi Y., and Flavell R.A. Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: Highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 16 (2002) 183-191
57. Gylling M., Kaariainen E., Vaisanen R., Kerosuo L., Solin M.L., Halme L., Saari S., Halonen M., Kampe O., Perheentupa J., and Miettinen A. The hypoparathyroidism of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: Protective effect of male sex. J. Clin. Endocrinol. Metab. 88 (2003) 4602-4608
58. Gylling M., Tuomi T., Bjorses P., Kontiainen S., Partanen J., Christie M.R., Knip M., Perheentupa J., and Miettinen A. ss-cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J. Clin. Endocrinol. Metab. 85 (2000) 4434-4440
59. Halonen M., Eskelin P., Myhre A.G., Perheentupa J., Husebye E.S., Kampe O., Rorsman F., Peltonen L., Ulmanen I., and Partanen J. AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype. J. Clin. Endocrinol. Metab. 87 (2002) 2568-2574
60. Halonen M., Kangas H., Ruppell T., Ilmarinen T., Ollila J., Kolmer M., Vihinen M., Palvimo J., Saarela J., Ulmanen I., and Eskelin P. APECED-causing mutations in AIRE reveal the functional domains of the protein. Hum. Mutat. 23 (2004) 245-257
61. Halonen M., Pelto-Huikko M., Eskelin P., Peltonen L., Ulmanen I., and Kolmer M. Subcellular location and expression pattern of autoimmune regulator (Aire), the mouse orthologue for human gene defective in autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED). J. Histochem. Cytochem. 49 (2001) 197-208
62. Hauben E., Bacchetta R., and Roncarolo M.G. Utilizing regulatory T cells to control alloreactivity. Cytotherapy 7 (2005) 158-165
63. Hedstrand H., Ekwall O., Haavik J., Landgren E., Betterle C., Perheentupa J., Gustafsson J., Husebye E., Rorsman F., and Kampe O. Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I. Biochem. Biophys. Res. Commun. 267 (2000) 456-461
64. Hedstrand H., Ekwall O., Olsson M.J., Landgren E., Kemp E.H., Weetman A.P., Perheentupa J., Husebye E., Gustafsson J., Betterle C., Kampe O., and Rorsman F. The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I. J. Biol. Chem. 276 (2001) 35390-35395
65. Heino M., Peterson P., Kudoh J., Nagamine K., Lagerstedt A., Ovod V., Ranki A., Rantala I., Nieminen M., Tuukkanen J., Scott H.S., Antonarakis S.E., Shimizu N., and Krohn K. Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla. Biochem. Biophys. Res. Commun. 257 (1999) 821-825
66. Heino M., Peterson P., Kudoh J., Shimizu N., Antonarakis S.E., Scott H.S., and Krohn K. APECED mutations in the autoimmune regulator (AIRE) gene. Hum. Mutat. 18 (2001) 205-211
67. Heino M., Peterson P., Sillanpaa N., Guerin S., Wu L., Anderson G., Scott H.S., Antonarakis S.E., Kudoh J., Shimizu N., Jenkinson E.J., Naquet P., and Krohn K.J. RNA and protein expression of the murine autoimmune regulator gene (Aire) in normal, RelB-deficient and in NOD mouse. Eur. J. Immunol. 30 (2000) 1884-1893
68. Heino M., Scott H.S., Chen Q., Peterson P., Maebpaa U., Papasavvas M.P., Mittaz L., Barras C., Rossier C., Chrousos G.P., Stratakis C.A., Nagamine K., Kudoh J., Shimizu N., Maclaren N., Antonarakis S.E., and Krohn K. Mutation analyses of North American APS-1 patients. Hum. Mutat. 13 (1999) 69-74
69. th Ed (2004), W.B. Saunders, Philadelphia 480-504
70. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
71. Husebye E.S., Gebre-Medhin G., Tuomi T., Perheentupa J., Landin-Olsson M., Gustafsson J., Rorsman F., and Kampe O. Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I. J. Clin. Endocrinol. Metab. 82 (1997) 147-150
72. Irvine W.J., and Scarth L. Antibody to the oxyphil cells of the human parathyroid in idiopathic hypoparathyroidism. Clin. Exp. Immunol. 4 (1969) 505-510
73. Johnnidis J.B., Venanzi E.S., Taxman D.J., Ting J.P., Benoist C.O., and Mathis D.J. Chromosomal clustering of genes controlled by the aire transcription factor. Proc. Natl. Acad. Sci. USA 102 (2005) 7233-7238
74. Jonas M.M., Bell M.D., Eidson M.S., Koutouby R., and Hensley G.T. Congenital diabetes mellitus and fatal secretory diarrhea in two infants. J. Pediatr. Gastroenterol. Nutr. 13 (1991) 415-425
75. Kaestner K.H., Knochel W., and Martinez D.E. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev. 14 (2000) 142-146
76. Kanangat S., Blair P., Reddy R., Daheshia M., Godfrey V., Rouse B.T., and Wilkinson E. Disease in the scurfy (sf) mouse is associated with overexpression of cytokine genes. Eur. J. Immunol. 26 (1996) 161-165
77. + T cell effector function. J. Immunol. 171 (2003) 1216-1223
78. + T regulatory cells. Nat. Immunol. 4 (2003) 337-342
79. Khattri R., Kasprowicz D., Cox T., Mortrud M., Appleby M.W., Brunkow M.E., Ziegler S.F., and Ramsdell F. The amount of scurfin protein determines peripheral T cell number and responsiveness. J. Immunol. 167 (2001) 6312-6320
80. Kobayashi I., Imamura K., Kubota M., Ishikawa S., Yamada M., Tonoki H., Okano M., Storch W.B., Moriuchi T., Sakiyama Y., and Kobayashi K. Identification of an autoimmune enteropathy-related 75-kilodalton antigen. Gastroenterology 117 (1999) 823-830
81. Kobayashi I., Imamura K., Yamada M., Okano M., Yara A., Ikema S., and Ishikawa N. A 75-kD autoantigen recognized by sera from patients with X-linked autoimmune enteropathy associated with nephropathy. Clin. Exp. Immunol. 111 (1998) 527-531
82. Kobayashi I., Kawamura N., and Okano M. A long-term survivor with the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. N. Engl. J. Med. 345 (2001) 999-1000
83. Kobayashi I., Nakanishi M., Okano M., Sakiyama Y., and Matsumoto S. Combination therapy with tacrolimus and betamethasone for a patient with X-linked auto-immune enteropathy. Eur. J. Pediatr. 154 (1995) 594-595
84. Kobayashi I., Shiari R., Yamada M., Kawamura N., Okano M., Yara A., Iguchi A., Ishikawa N., Ariga T., Sakiyama Y., Ochs H.D., and Kobayashi K. Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX). J. Med. Genet. 38 (2001) 874-876
85. Kogawa K., Nagafuchi S., Katsuta H., Kudoh J., Tamiya S., Sakai Y., Shimizu N., and Harada M. Expression of AIRE gene in peripheral monocyte/dendritic cell lineage. Immunol. Lett. 80 (2002) 195-198
86. Kumar P.G., Laloraya M., Wang C.Y., Ruan Q.G., Davoodi-Semiromi A., Kao K.J., and She J.X. The autoimmune regulator (AIRE) is a DNA-binding protein. J. Biol. Chem. 276 (2001) 41357-41364
87. Kuroda N., Mitani T., Takeda N., Ishimaru N., Arakaki R., Hayashi Y., Bando Y., Izumi K., Takahashi T., Nomura T., Sakaguchi S., Ueno T., Takahama Y., Uchida D., Sun S., Kajiura F., Mouri Y., Han H., Matsushima A., Yamada G., and Matsumoto M. Development of autoimmunity against transcriptionally unrepressed target antigen in the thymus of Aire-deficient mice. J. Immunol. 174 (2005) 1862-1870
88. + and type 1 regulatory T cells. Curr. Top. Microbiol. Immunol. 293 (2005) 303-326
89. Levy-Lahad E., and Wildin R.S. Neonatal diabetes mellitus, enteropathy, thrombocytopenia, and endocrinopathy: Further evidence for an X-linked lethal syndrome. J. Pediatr. 138 (2001) 577-580
90. Li Y., Song YH., Rais N., Connor E., Schatz D., Muir A., and Maclaren N. Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J. Clin. Invest. 97 (1996) 910-914
91. Liston A., Gray D.H.D., Lesage S., Fletcher A.L., Wilson J., Webster K.E., Scott H.S., Boyd R.L., Peltonen L., and Goodnow C.C. Gene dosage-limiting role of aire in thymic expression, clonal deletion, and organ-specific autoimmunity. J. Exp. Med. 200 (2004) 1015-1026
92. Liston A., Lesage S., Wilson J., Peltonen L., and Goodnow C.C. Aire regulates negative selection of organ-specific T cells. Nat. Immunol. 4 (2003) 350-354
93. Lyon M.F., Peters J., Glenister P.H., Ball S., and Wright E. The scurfy mouse mutant has previously unrecognized hematological abnormalities and resembles Wiskott-Aldrich syndrome. Proc. Natl. Acad. Sci. USA 87 (1990) 2433-2437
94. Ma Y., Pannicke U., Schwarz K., and Lieber M.R. Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in non-homologous endjoining and V(D)J recombination. Cell 108 (2002) 781-794
95. Markert M.L., Alexieff M.J., Li J., Sarzotti M., Ozaki D.A., Devlin B.H., Sempowski G.D., Rhein M.E., Szabolcs P., Hale L.P., Buckley R.H., Coyne K.E., Rice H.E., Mahaffey S.M., and Skinner M.A. Complete DiGeorge syndrome: Development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases. J. Allergy Clin. Immunol. 113 (2004) 734-741
96. Marquis E., Robert J.J., Bouvattier C., Bellanne-Chantelot C., Junien C., and Diatloff-Zito C. Major difference in aetiology and phenotypic abnormalities between transient and permanent neonatal diabetes. J. Med. Genet. 39 (2002) 370-374
97. Martin J.V., Willoughby P.B., Giusti V., Price G., and Cerezo L. The lymph node pathology of Omenn's syndrome. Am. J. Surg. Pathol. 19 (1995) 1082-1087
98. Mazzolari E., Forino C., Fontana M., D'Ippolito C., Lanfranchi A., Gambineri E., Ochs H., Badolato R., and Notarangelo L.D. A new case of IPEX receiving bone marrow transplantation. Bone Marrow Transplant. 35 (2005) 1033-1034
99. Mazzolari E., Moshous D., Forino C., DeMartiis D., Offer C., Lanfranchi A., Giliani S., Imberti L., Pasic S., Ugazio A.G., Porta F., and Notarangelo L.D. Hematopoietic stem cell transplantation in Omenn syndrome: A single-center experience. Bone Marrow Transplant. 36 (2005) 107-114
100. Means G.D., Toy D.Y., Baum P.R., and Derry J.M. A transcript map of a 2-Mb BAC contig in the proximal portion of the mouse X chromosome and regional mapping of the scurfy mutation. Genomics 65 (2000) 213-223
101. Meloni A., Fiorillo E., Corda D., Perniola R., Cao A., and Rosatelli M.C. Two novel mutations of the AIRE protein affecting its homodimerization properties. Hum. Mutat. 25 (2005) 319
102. Meloni A., Perniola R., Faa V., Corvaglia E., Cao A., and Rosatelli M.C. Delineation of the molecular defects in the AIRE gene in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients from Southern Italy. J. Clin. Endocrinol. Metab. 87 (2002) 841-846
103. Moshous D., Callebaut I., de Chasseval R., Corneo B., Cavazzana-Calvo M., Le Deist F., Tezcan I., Sanal O., Bertrand Y., Philippe N., Fischer A., and de Villartay J.P. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105 (2001) 177-186
104. Nagamine K., Peterson P., Scott H.S., Kudoh J., Minoshima S., Heino M., Krohn K.J., Lalioti M.D., Mullis P.E., Antonarakis S.E., Kawasaki K., Asakawa S., Ito F., and Shimizu N. Positional cloning of the APECED gene. Nat. Genet. 17 (1997) 393-398
105. Nieves D.S., Phipps R.P., Pollock S.J., Ochs H.D., Zhu Q., Scott G.A., Ryan C.K., Kobayashi I., Rossi T.M., and Goldsmith L.A. Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Arch. Dermatol. 140 (2004) 466-472
106. Noordzij J.G., de Bruin-Versteeg S., Verkaik N.S., Vossen J.M.J.J., de Groot R., Bernatowska E., Langerak A.W., van Gent D.C., and van Dongen J.J.M. The immunophenotypic and immunogenotypic B cell differentiation arrest in bone marrow of RAG-deficient SCID corresponds to residual recombination activities of mutated RAG proteins. Blood 100 (2000) 2145-2152
107. Noordzij J.G., Verkaik N.S., Hartwig N.G., de Groot R., van Gent D.C., and van Dongen J.J.M. N-terminal truncated RAG1 proteins can direct T cell receptor but not immunoglobulin gene rearrangements. Blood 96 (2000) 203-209
108. Notarangelo L.D., Stoppoloni G., Toraldo R., Mazzolari E., Coletta A., Airò P., Bordignon C., and Ugazio A.G. Insulin-dependent diabetes mellitus and severe atopic dermatitis in a child with adenosine deaminase deficiency. Eur. J. Pediatr. 151 (1992) 811-814
109. Notarangelo L.D., and Hayward A.R. X-linked immunodeficiency with hyper-IgM (XHIM). Clin. Exp. Immunol. 120 (2000) 399-405
110. Obermayer-Straub P., Perheentupa J., Braun S., Kayser A., Barut A., Loges S., Harms A., Dalekos G., Strassburg C.P., and Manns M.P. Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Gastroenterology 121 (2001) 668-677
111. Ochs H.D., Ziegler S.F., and Torgerson T.R. FOXP3 acts as a rheostat of the immune response. Immunol. Rev. 203 (2005) 156-164
112. Omenn G.S. Familial reticuloendothleiosis with eosinophilia. N. Engl. J. Med. 273 (1965) 427-432
113. Owen C.J., Jennings C.E., Imrie H., Lachaux A., Bridges N.A., Cheetham T.D., and Pearce S.H. Mutational analysis of the FOXP3 gene and evidence for genetic heterogeneity in the immunodysregulation, polyendocrinopathy, enteropathy syndrome. J. Clin. Endocrinol. Metab. 88 (2003) 6034-6039
114. Peake J.E., McCrossin R.B., Byrne G., and Shepherd R. X-linked immune dysregulation, neonatal insulin dependent diabetes, and intractable diarrhoea. Arch. Dis. Child Fetal Neonatal Ed. 74 (1996) F195-F199
115. Pearce S.H., Cheetham T., Imrie H., Vaidya B., Barnes N.D., Bilous R.W., Carr D., Meeran K., Shaw N.J., Smith C.S., Toft A.D., Williams G., and Kendall-Taylor P. A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1. Am. J. Hum. Genet. 63 (1998) 1675-1684
116. Perniola R., Falorni A., Clemente M.G., Forini F., Accogli E., and Lobreglio G. Organ-specific and non-organ-specific autoantibodies in children and young adults with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). Eur. J. Endocrinol. 143 (2000) 497-503
117. Pirovano S., Mazzolari E., Pasic S., Alberini A., Notarangelo L.D., and Imberbti L. Impaired thymic output and restricted T cell repertoire in two infants with immunodeficiency and early-onset generalized dermatitis. Immunol. Lett. 86 (2003) 93-97
118. Pitkanen J., Doucas V., Sternsdorf T., Nakajima T., Aratani S., Jensen K., Will H., Vahamurto P., Ollila J., Vihinen M., Scott H.S., Antonarakis S.E., Kudoh J., Shimizu N., Krohn K., and Peterson P. The autoimmune regulator protein has transcriptional transactivating properties and interacts with the common coactivator CREB-binding protein. J. Biol. Chem. 275 (2000) 16802-16809
119. Pitkanen J., Vahamurto P., Krohn K., and Peterson P. Subcellular localization of the autoimmune regulator protein. Characterization of nuclear targeting and transcriptional activation domain. J. Biol. Chem. 276 (2001) 19597-19602
120. Pitkanen J., Doucas V., Sternsdorf T., Nakajima T., Aratani S., Jensen K., Will H., Vahamurto P., Ollila J., Vihinen M., Scott H.S., Antonarakis S.E., Kudoh J., Shimizu N., Krohn K., and Peterson P. The autoimmune regulator protein has transcriptional transactivating properties and interacts with the common coactivator CREB-binding protein. J. Biol. Chem. 275 (2000) 16802-16809
121. Powell B.R., Buist N.R., and Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J. Pediatr. 100 (1982) 731-737
122. Qian X., and Costa R.H. Analysis of hepatocyte nuclear factor-3 beta protein domains required for transcriptional activation and nuclear targeting. Nucleic Acids Res. 23 (1995) 1184-1191
123. Ramsey C., Winqvist O., Puhakka L., Halonen M., Moro A., Kampe O., Eskelin P., Pelto-Huikko M., and Peltonen L. Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum. Mol. Genet. 11 (2002) 397-409
124. Rieux-Laucat F., Bahadoran P., Brousse N., Selz F., Fischer A., Le Deist F., and de Villartay J.P. Highly restricted human T cell repertoire in peripheral blood and tissue-infiltrating lymphocytes in Omenn's syndrome. J. Clin. Invest. 102 (1998) 312-321
125. Rinderle C., Christensen H.M., Schweiger S., Lehrach H., and Yaspo M.L. AIRE encodes a nuclear protein co-localizing with cytoskeletal filaments: Altered subcellular distribution of mutants lacking the PHD zinc fingers. Hum. Mol. Genet. 8 (1999) 277-290
126. Roberts J., and Searle J. Neonatal diabetes mellitus associated with severe diarrhea, hyperimmunoglobulin E syndrome, and absence of islets of Langerhans. Pediatr. Pathol. Lab. Med. 15 (1995) 477-483
127. Rosatelli M.C., Meloni A., Devoto M., Cao A., Scott H.S., Peterson P., Heino M., Krohn K.J., Nagamine K., Kudoh J., Shimizu N., and Antonarakis S.E. A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. Hum. Genet. 103 (1998) 428-434
128. Russell W.L., Russell L.B., and Gower J.S. Exceptional inheritance of a sex-linked gene in the mouse explained on the basis that the X/O sex chromosome constitution is female. Proc. Natl. Acad. Sci. USA 45 (1959) 554-560
129. + regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22 (2004) 531-562
130. + regulatory T cells: Their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182 (2001) 18-32
131. Saleem M.A., Arkwright P.D., Davies E.G., Cant A.J., and Veys P. Clinical course of patients with major histocompatibility complex class II deficiency. Arch. Dis. Child 83 (2000) 356-359
132. Santagata S., Besmer E., Villa A., Bozzi F., Allingham J.S., Sobacchi C., Haniford D.B., Vezzoni P., Nussenzweig M.C., Pan Z.Q., and Cortes P. The RAG1/RAG2 complex constitutes a 3′ flap endonuclease: Implications for junctional diversità in V(D)J and transpositional recombination. Mol. Cell 4 (1999) 1-20
133. Santagata S., Gomez C.A., Sobacchi C., Bozzi F., Abinun M., Pasic S., Cortes P., Vezzoni P., and Villa A. N-terminal RAG1 frameshift mutations in Omenn's syndrome: Internal methionine usage leads to partial V(D)J recombination activity and reveals a fundamental role in vivo for the N-terminal domains. Proc. Natl. Acad. Sci. USA 19 (2000) 14572-14577
134. Satake N., Nakanishi M., Okano M., Tomizawa K., Ishizaka A., Kojima K., Onodera M., Ariga T., Satake A., Sakiyama Y., et al. A Japanese family of X-linked auto-immune enteropathy with haemolytic anaemia and polyendocrinopathy. Eur. J. Pediatr. 152 (1993) 313-315
135. Schandené L., Ferster A., Mascart-Lemone F., Crusiaux A., Gérard C., Marchant A., Lybin M., Velu T., Sariban E., and Goldman M. T helper 2-like cells and therapeutic effects of interferon-γ in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). Eur. J. Immunol. 23 (1993) 56-60
136. Schubert L.A., Jeffery E., Zhang Y., Ramsdell F., and Ziegler S.F. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 276 (2001) 37672-37679
137. Schurman S.H., and Candotti F. Autoimmunity in Wiskott-Aldrich syndrome. Curr. Opin. Rheumatol. 15 (2003) 446-453
138. Schwarz K., Gauss G.H., Ludwig L., Pannicke U., Li Z., Lindner D., Friedrich W., Seger R.A., Hansen-Hagge T.E., Desiderio S., and Lieber M.R. RAG mutations in human B cell-negative SCID. Science 274 (1996) 97-99
139. Scott H.S., Heino M., Peterson P., Mittaz L., Lalioti M.D., Betterle C., Cohen A., Seri M., Lerone M., Romeo G., Collin P., Salo M., Metcalfe R., Weetman A., Papasavvas M.P., Rossier C., Nagamine K., Kudoh J., Shimizu N., Krohn K.J., and Antonarakis S.E. Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different origins. Mol. Endocrinol. 12 (1998) 1112-1119
140. Sharfe N., Dadi H.K., Shahar M., and Roifman C.M. Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor. Proc. Natl. Acad. Sci. USA 94 (1997) 3168-3171
141. + suppressor T cells: More questions than answers. Nat. Rev. Immunol. 2 (2002) 389-400
142. Shigeoka A.O., Araneo B., Carey J., and Rallison M. An X-linked T cell activation syndrome and response to Cyclosporin A in one affected infant. Pediatr. Res. 29 (1991) 163A
143. Shu W., Yang H., Zhang L., Lu M.M., and Morrisey E.E. Characterization of a new subfamily of winged-helix/forkhead (Fox) genes that are expressed in the lung and act as transcriptional repressors. J. Biol. Chem. 276 (2001) 27488-27497
144. Signorini S., Imberti L., Pirovano S., Villa A., Facchetti F., Ungari M., Bozzi F., Albertini A., Ugazio A.G., Vezzoni P., and Notarangelo L.D. Intrathymic restriction and peripheral expansion of the T cell repertoire in Omenn syndrome. Blood 94 (1999) 3468-3478
145. Soderbergh A., Myhre A.G., Ekwall O., Gebre-Medhin G., Hedstrand H., Landgren E., Miettinen A., Eskelin P., Halonen M., Tuomi T., Gustafsson J., Husebye E.S., Perheentupa J., Gylling M., Manns M.P., Rorsman F., Kampe O., and Nilsson T. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J. Clin. Endocrinol. Metab. 89 (2004) 557-562
146. Sternsdorf T., Jensen K., Reich B., and Will H. The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J. Biol. Chem. 274 (1999) 12555-12566
147. Szczepanski T., Beishuizen A., Pongers-Willemse M.J., Hahlen K., van Wering E.R., Wijkhuijs A.G., Tibbe G.J., de Bruijn M.A., and van Dongen J.J. Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: Alternative PCR targets for detection of minimal residual disease. Leukemia 13 (1999) 196-205
148. Szczepanski T., Pongers-Willemse M.J., Langerak A.W., Harts W.A., Wijkhuis A.J., van Wering E.R., and van Dongen J.J. Ig heavy chain gene rearrangements in T cell acute lymphoblastic leukaemia exhibit predominant DH6-19 and DH-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T cell receptor alpha beta lineage. Blood 93 (1999) 4079-4085
149. Tai X., Cowan M., Feigenbaum L., and Singer A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat. Immunol. 6 (2005) 152-162
150. The Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. The Finnish-German APECED Consortium. Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy. Nat. Genet. 17 (1997) 399-403
151. + T cell suppressor function. J. Immunol. 172 (2004) 6519-6523
152. Tommasini A., Ferrari S., Moratto D., Badolato R., Boniotto M., Pirulli D., Notarangelo L.D., and Andolina M. X chromosome inactivation analysis in a female carrier of FOXP3 mutation. Clin. Exp. Immunol. 130 (2002) 127-130
153. Uchida D., Hatakeyama S., Matsushima A., Han H., Ishido S., Hotta H., Kudoh J., Shimizu N., Doucas V., Nakayama K.I., Kuroda N., and Matsumoto M. AIRE functions as an E3 ubiquitin ligase. J. Exp. Med. 199 (2004) 167-172
154. Villa A., Santagata S., Bozzi F., Giliani S., Frattini A., Imberti L., Benerini Gatta L., Ochs H.D., Schwarz K., Notarangelo L.D., Vezzoni P., and Spanopoulou E. Partial V(D)J recombination activity leads to Omenn syndrome. Cell 93 (1998) 885-896
155. Villa A., Sobacchi C., Notarangelo L.D., Bozzi F., Abinun M., Abrahamsen T.G., Arkwright P.D., Baniyash M., Brooks E.G., Conley M.E., Cortes P., Duse M., Fasth A., Filipovich A.M., Infante A.J., Jones A., Mazzolari E., Muller S.M., Pasic S., Rechavi G., Sacco M.G., Santagata S., Schroeder M.L., Seger, R. S., D., Ugazio A., Valiaho J., Vihinen M., Vogler L.B., Ochs H.D., Vezzoni P., Friedrich W., and Schwarz K. V(D)J recombination defects in lymphocytes due to RAG mutations: Severe immunodeficiency with a spectrum of clinical presentations. Blood 97 (2001) 81-88
156. Wada T., Takei K., Kudo M., Shimura S., Kasahara Y., Koizumi S., Kawa-Ha K., Ishida Y., Imashuku S., Seki H., and Yachie A. Characterization of immune function and analysis of RAG gene mutations in Omenn syndrome and related disorders. Clin. Exp. Immunol. 119 (2000) 148-155
157. Wada T., Toma T., Okamoto H., Kasahara Y., Koizumi S., Agematsu K., Kimura H., Shimada A., Hayashi Y., Kato M., and Yachie A. Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency. Blood 106 (2005) 2099-2101
158. - T cells. J. Clin. Invest. 112 (2003) 1437-1443
159. Walport M.J., Davies K.A., Morley B.J., and Botto M. Complement deficiency and autoimmunity. Ann. N. Y. Acad. Sci. 815 (1997) 267-281
160. Wang C.Y., Davoodi-Semiromi A., Huang W., Connor E., Shi J.D., and She J.X. Characterization of mutations in patients with autoimmune polyglandular syndrome type 1 (APS1). Hum. Genet. 103 (1998) 681-685
161. Ward L., Paquette J., Seidman E., Huot C., Alvarez F., Crock P., Delvin E., Kampe O., and Deal C. Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: Response to immunosuppressive therapy. J. Clin. Endocrinol. Metab. 84 (1999) 844-852
162. Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N., Levy-Lahad E., Mazzella M., Goulet O., Perroni L., Bricarelli F.D., Byrne G., McEuen M., Proll S., Appleby M., and Brunkow M.E. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27 (2001) 18-20
163. Wildin R.S., Smyk-Pearson S., and Filipovich A.H. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J. Med. Genet. 39 (2002) 537-545
164. Wirt D.P., Brooks E.G., Vaidya S., Klimpel G.R., Waldmann T.A., and Goldblum R.M. Novel T-lymphocyte population in combined immunodeficiency with features of graft versus host disease. N. Engl. J. Med. 321 (1989) 370-374
165. Zlotogora J., and Shapiro M.S. Polyglandular autoimmune syndrome type I among Iranian Jews. J. Med. Genet. 29 (1992) 824-826
166. Zuklys S., Balciunaite G., Agarwal A., Fasler-Kan E., Palmer E., and Hollander G.A. Normal thymic architecture and negative selection are associated with Aire expression, the gene defective in the autoimmune-polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). J. Immunol. 165 (2000) 1976-1983